No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1574 |
4. Check minimum number of eventsNone |
1574 |
5. Include endpointsNone |
1574 |
6. Filter based on genotype QC (FinnGen only) |
1574 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Aliae malformationes congenitae cutis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of skin
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17324 | 10148 | 7145 |
| Only index persons | 13543 | 8120 | 5423 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.29 | 0.20 |
| Only index persons | 0.26 | 0.30 | 0.21 |
| Median age at first event (years) | |||
| Whole population | 14.42 | 16.84 | 10.89 |
| Only index persons | 23.76 | 27.52 | 18.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1574 | 1052 | 522 |
| Unadjusted period prevalence (%) | 0.32 | 0.36 | 0.23 |
| Median age at first event (years) | 42.20 | 39.72 | 47.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1418
- Matched controls
- 14182
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
494.5
323.0
566
19
Q82.50
ICD-10 Finland
Naevus flammeus
+∞
251.8
234
*
Q82.2
ICD-10 Finland
Mastocytosis
2158.0
188.8
179
*
ZXC12
NOMESCO Finland
Pulse colorlaser
262.6
140.9
142
6
Q82.51
ICD-10 Finland
Naevus portwine
361.1
130.8
130
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
109.1
127.6
138
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.8
111.3
311
565
Q82.88
ICD-10 Finland
Other specified congenital malformations of skin
+∞
93.8
89
*
Q82.5
ICD-10 Finland
Congenital non-neoplastic naevus
127.4
78.8
84
7
ZQX00
NOMESCO Finland
0-4% of the skin
271.3
76.2
77
*
Q82.80
ICD-10 Finland
Benign familial pemphigus [Hailey-Hailey]
+∞
71.5
68
*
D18.0
ICD-10 Finland
Haemangioma, any site
10.5
54.0
108
110
Q82.0
ICD-10 Finland
Hereditary lymphoedema
+∞
53.5
51
*
Q82.82
ICD-10 Finland
Inherited keratosis palmaris et plantaris
+∞
50.3
48
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
12.1
47.9
89
78
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
+∞
44.0
42
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
42.6
174
456
Q82.81
ICD-10 Finland
Keratosis follicularis [Darier-White]
+∞
41.9
40
*
Q82.9
ICD-10 Finland
Congenital malformation of skin, unspecified
+∞
38.7
37
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
376.8
37.2
37
*
Q82.8
ICD-10 Finland
Other specified congenital malformations of skin
+∞
32.4
31
*
9741/3-C42.1
ICD-O-3
Malignant mastocytosis of bone marrow
+∞
30.3
29
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.7
29.4
138
405
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
12.8
26.4
47
38
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
8.8
24.2
52
61
E0000UV
ATC
NA
1.8
23.3
596
4077
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.2
22.8
72
144
ZXC10
NOMESCO Finland
Use of laser
6.3
22.6
61
101
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
6.4
22.3
59
95
D05BB02
ATC
acitretin; oral
5.8
22.1
63
112
Q82.4
ICD-10 Finland
Ectodermal dysplasia (anhidrotic)
+∞
21.9
21
*
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
81.4
21.7
24
*
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
19.8
19
*
QDA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of lower limb
31.8
19.3
25
8
C01CA24
ATC
epinephrine; parenteral
2.7
18.9
133
516
E000001
ATC
NA
1.9
17.4
317
1898
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
16.8
376
2409
Q82.1
ICD-10 Finland
Xeroderma pigmentosum
+∞
16.7
16
*
2280A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Haemangioma, any site
91.1
16.6
18
*
XQ848
NOMESCO Finland
Dermatological photography
4.5
15.9
57
132
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.1
15.6
189
967
Z31.5
ICD-10 Finland
Genetic counselling
2.8
15.2
98
363
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
15.0
245
1406
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.5
14.7
69
204
Q82.3
ICD-10 Finland
Incontinentia pigmenti
+∞
14.6
14
*
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
+∞
14.6
14
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
14.3
14.6
24
17
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
12.7
14.4
25
20
D07AC01
ATC
betamethasone; topical
1.6
14.1
422
2915
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
13.9
67
203
D02AE01
ATC
carbamide; topical
2.4
13.6
113
484
Q27.4
ICD-10 Finland
Congenital phlebectasia
75.9
13.6
15
*
Q82.83
ICD-10 Finland
Congenital dyskeratosis
+∞
13.6
13
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
13.6
13
*
J01DB01
ATC
cefalexin; oral
1.6
13.5
1105
9694
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.1
13.4
76
257
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.9
13.3
82
295
B07.9
ICD-10 Finland
Verruca simplex
3.2
13.2
71
233
D02AX
ATC
Other emollients and protectives
2.9
13.1
80
284
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
15.2
13.1
21
14
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.2
353
2400
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
12.1
93
382
ZXA00
NOMESCO Finland
Right side
1.7
12.0
306
2009
L82
ICD-10 Finland
Seborrhoeic keratosis
1.9
11.6
175
973
S18
ICPC
Laceration/cut
1.5
11.2
492
3688
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
20.2
11.1
16
8
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
11.2
11.1
20
18
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
7.5
11.0
25
34
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.5
10.9
89
377
D07AC13
ATC
mometasone; topical
1.6
10.9
360
2521
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
4.4
10.8
38
88
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
28.2
10.7
14
5
D07XC01
ATC
betamethasone, combinations; topical
1.9
10.4
151
826
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.0
10.4
139
739
A02BA02
ATC
ranitidine; systemic
1.7
10.2
216
1338
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
10.0
78
324
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.6
10.0
43
121
XQ800
NOMESCO Finland
Prick test
2.0
9.9
125
646
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
9.7
170
993
L57.0
ICD-10 Finland
Actinic keratosis
2.2
9.5
93
433
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
17.7
9.4
14
8
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
9.4
9
*
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
9.2
267
1801
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.1
337
2411
R4110
NOMESCO Finland
Physiotherapy
1.5
9.1
310
2175
XQ845
NOMESCO Finland
Dermatoscopy
5.1
9.0
27
54
R06AE07
ATC
cetirizine; oral
1.4
8.9
570
4552
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
7.5
8.9
20
27
I78.9
ICD-10 Finland
Disease of capillaries, unspecified
12.6
8.9
15
12
ZXA10
NOMESCO Finland
Bilateral
1.7
8.8
212
1358
D07AA02
ATC
hydrocortisone; topical
1.7
8.8
201
1271
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.8
184
1137
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
4.9
8.7
27
56
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
14.1
8.7
14
10
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.9
8.7
131
727
ZXA05
NOMESCO Finland
Left side
1.6
8.6
266
1824
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
8.6
159
948
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
5.1
8.3
25
50
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
8.3
8
*
7573E
ICD-9 Finland
Congenital anomalies of the integument, Other specified anomalies of skin[URTICARIA PIGMENTOSA (MASTOCYTOSIS)]
+∞
8.3
8
*
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
10.8
8.3
15
14
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.3
8.3
39
119
ZXC50
NOMESCO Finland
Cryotherapy
3.2
8.2
41
131
N02BE01
ATC
paracetamol; systemic, rectal
1.4
8.2
1076
9718
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
8.1
466
3632
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
8.2
8.1
17
21
QAA10
NOMESCO Finland
Incision of skin of head or neck
11.8
8.1
14
12
E000002
ATC
NA
1.7
7.9
161
987
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
7.0
7.8
18
26
Q82
ICD-10 Finland
Other congenital malformations of skin
45.2
7.7
9
*
UJF32
NOMESCO Finland
Coloscopy
1.5
7.6
268
1887
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.6
307
2230
D07AD01
ATC
clobetasol; topical
1.6
7.5
181
1163
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.4
7.4
61
261
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
7.4
168
1061
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
7.4
160
998
WX110
NOMESCO Finland
Local anesthesy
1.4
7.4
909
8021
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.3
7.4
35
108
J01AA02
ATC
doxycycline; systemic
1.4
7.3
925
8193
S29
ICPC
Skin symptom/complaint other
1.6
7.3
204
1358
CBB15
NOMESCO Finland
Resection of herniated fat from eyelid
+∞
7.3
7
*
QAE50
NOMESCO Finland
Dermabrasion of superficial lesion of skin of head or neck
+∞
7.3
7
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
7.3
7
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
7.2
147
901
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.2
206
1381
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.4
7.2
33
100
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.4
7.2
33
100
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.1
309
2272
D07AB08
ATC
desonide; topical
1.7
7.0
135
812
J01FA10
ATC
azithromycin; systemic
1.3
7.0
789
6836
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.0
7.0
26
66
127
Kela drug reimbursment
Transplant complication
3.6
6.9
29
82
QBA10
NOMESCO Finland
Incision of skin of trunk
4.8
6.8
21
44
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
6.8
86
450
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.7
6.8
16
24
N03AX12
ATC
gabapentin; oral
1.6
6.8
166
1073
A02BC05
ATC
esomeprazole; systemic
1.4
6.7
437
3460
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
4.3
6.7
23
54
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.7
449
3573
M25.5
ICD-10 Finland
Pain in joint
1.4
6.6
336
2546
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
6.9
6.5
15
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
6.5
97
538
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
6.4
98
547
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.4
766
6654
J01FF01
ATC
clindamycin; systemic
1.4
6.4
304
2270
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.1
6.3
31
100
C03CA01
ATC
furosemide; systemic
1.5
6.3
228
1616
L85.1
ICD-10 Finland
Acquired keratosis [keratoderma] palmaris et plantaris
18.1
6.3
9
5
9744
FHL
NA
+∞
6.3
6
*
Q82.86
ICD-10 Finland
Gorlins syndrome
+∞
6.3
6
*
Q82.52
ICD-10 Finland
Mongolian blue spot
+∞
6.3
6
*
Q82.84
ICD-10 Finland
Pseudoxanthoma elasticum
+∞
6.3
6
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.9
6.2
87
471
M79.6
ICD-10 Finland
Pain in limb
1.4
6.2
406
3210
-
ICD-10 Finland
NA
3.1
6.1
31
102
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.1
78
409
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.1
138
873
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
6.1
55
249
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
6.1
37
137
J02AC01
ATC
fluconazole; systemic
1.3
6.1
490
4003
L04AA06
ATC
mycophenolic acid; systemic
3.4
6.1
27
81
R06AX27
ATC
desloratadine; oral
1.4
6.0
374
2929
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
6.0
62
298
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
228
1156
2.14
22.43
6.1
4.2
212.0
256.7
u/l
3.82
221
1100
717
5230
1.68
21.91
2.8
2.4
75.6
75.1
nmol/l
0.20
667
4781
938
7491
1.62
18.88
9.8
9.0
4.0
4.0
e9/l
0.07
849
6561
660
4918
1.59
17.19
5.4
4.9
36.4
36.3
g/l
0.18
618
4592
186
990
2.00
15.83
1.5
1.3
146.5
222.0
u/ml
1.18
169
920
737
5758
1.53
14.82
7.9
7.2
1.2
1.2
mmol/l
0.35
651
4890
1084
9278
1.54
13.64
8.1
7.0
80.4
79.3
u/l
0.30
1040
8732
669
5243
1.48
12.56
7.4
6.7
1.2
1.2
mmol/l
0.14
627
4775
202
1212
1.76
11.72
3.1
3.5
1.6
1.8
%
0.97
189
1089
398
2853
1.53
11.29
2.0
1.9
1.2
1.1
mg/l
0.11
306
2115
1246
11242
1.52
10.11
18.7
15.0
13.7
13.5
%
1.57
1230
11014
218
1394
1.65
9.97
2.9
3.2
7.1
7.3
umol/l
0.06
187
1187
21
44
4.82
9.55
2.8
3.3
83.3
107.5
ug/l
0.31
21
44
245
1632
1.59
9.47
2.3
2.4
2.4
2.4
g/l
0.07
228
1507
1056
9279
1.42
9.39
4.4
3.9
10.8
10.8
mm/h
0.04
1014
8623
263
1796
1.56
9.11
2.4
2.4
13.1
13.8
umol/l
0.90
248
1657
227
1505
1.59
8.93
2.5
2.5
21.8
23.4
%
0.74
190
1306
737
6134
1.38
8.83
6.3
6.0
10.8
12.0
umol/l
1.91
704
5781
500
3937
1.40
8.24
3.2
3.3
2.4
2.4
mmol/l
0.22
441
3495
286
2031
1.50
8.21
3.3
3.5
431.1
489.8
ng/l
0.10
187
1409
431
3318
1.41
8.07
3.5
3.0
0.3
0.4
e6/l
0.25
325
2481
429
3307
1.41
7.95
2.3
2.2
492.4
231.5
u/l
0.80
412
3122
83
424
2.01
7.94
1.5
2.2
1.3
1.5
g/l
0.60
64
373
264
1865
1.50
7.75
4.9
4.3
0.8
0.8
mmol/l
0.67
245
1742
403
3086
1.41
7.73
2.5
2.2
2.8
2.9
mg/l
0.42
349
2647
231
1605
1.51
7.32
6.7
6.5
1.1
1.1
mmol/l
0.75
220
1498
274
1993
1.45
6.90
3.0
2.7
1.4
1.1
e6/l
0.28
155
1112
330
2490
1.41
6.79
2.8
2.5
10.6
7.2
e6/l
0.28
292
2203
720
6150
1.31
6.54
3.3
2.8
103.0
97.4
ug/l
0.23
680
5746
548
4524
1.32
6.29
2.1
1.8
95.5
96.2
pmol/l
0.15
281
2377
186
1275
1.52
6.27
2.1
1.8
—
—
—
0
0
243
1761
1.45
6.21
2.3
2.5
29.4
29.7
s
0.29
237
1711
246
1792
1.44
6.11
2.3
1.8
—
—
—
0
0
267
1980
1.42
6.01
3.2
2.7
2.4
2.4
mmol/l
0.22
231
1736
1117
10212
1.32
5.83
4.5
4.0
14.4
14.6
pmol/l
2.67
1041
9373
166
1130
1.52
5.78
2.7
2.3
29.2
81.2
u/l
0.64
146
944
180
1247
1.50
5.77
2.3
2.2
358.8
372.3
nmol/l
0.39
169
1160
182
1264
1.50
5.76
2.1
1.8
—
—
—
0
0
61
317
1.96
5.64
1.9
2.0
3169.2
760.1
e6/l
0.43
47
245
61
317
1.96
5.64
1.8
2.0
47.0
8.7
e6/l
0.74
44
236
1376
13025
1.45
5.57
15.5
12.3
19.5
21.8
mg/l
2.25
1098
10079
33
134
2.49
5.55
1.5
1.4
446.6
417.4
pmol/l
0.08
28
104
1274
11911
1.37
5.48
5.4
4.7
1.9
2.1
mu/l
0.58
1210
11052
19
57
3.36
5.45
1.1
1.1
0.3
0.3
g/l
0.55
14
48
252
1883
1.40
5.41
3.0
2.9
4.0
2.8
e6/l
0.45
132
1005
427
3464
1.32
5.39
1.4
1.3
1.0
1.8
u/ml
1.70
97
905
8
6
13.39
5.08
1.0
1.0
—
—
—
0
0
799
7066
1.27
5.03
5.9
4.8
6.4
6.5
mmol/l
0.61
741
6515
62
339
1.86
4.97
1.8
2.4
10.6
10.4
g/l
0.11
51
293
146
1004
1.50
4.86
8.5
8.7
8.4
8.1
mmol/l
0.16
141
966
1315
12425
1.36
4.72
17.2
13.1
39.9
39.9
%
0.02
1052
9612
115
758
1.56
4.66
2.9
3.1
129.8
178.2
ng/l
1.27
102
686
120
800
1.54
4.63
2.4
2.3
6.7
7.1
ug/l
0.10
110
714
38
179
2.15
4.62
1.2
1.3
—
—
—
0
0
121
812
1.53
4.53
2.0
3.0
67.4
66.7
g/l
0.45
111
749
64
365
1.79
4.51
1.9
2.4
7.0
7.4
g/l
1.08
50
285
64
365
1.79
4.51
1.9
2.4
—
—
—
0
0
54
292
1.88
4.51
1.9
3.9
39.5
71.3
mg/l
0.80
42
239
358
2898
1.30
4.50
3.0
2.6
4276.8
4776.0
umol/l
0.09
328
2544
926
8393
1.25
4.49
4.9
4.2
1188.8
2305.4
e6/l
0.49
11
109
496
4191
1.27
4.44
3.4
3.3
29.4
31.3
u/l
0.89
462
3989
1353
12871
1.37
4.40
17.0
13.6
139.6
139.6
mmol/l
0.14
1331
12515
61
346
1.79
4.38
1.9
2.4
3.1
3.1
g/l
0.01
50
276
1419
13615
1.43
4.30
11.4
9.5
26.1
26.1
u/l
0.01
1391
13180
63
365
1.76
4.23
1.9
2.4
3.7
3.7
g/l
0.04
49
272
669
5875
1.24
4.22
4.0
4.0
—
—
—
0
0
317
2546
1.31
4.20
1.6
1.5
20.5
20.7
nmol/l
0.09
285
2188
53
292
1.84
4.20
1.9
4.0
26.1
45.1
mg/l
1.03
42
239
1354
12902
1.36
4.18
17.1
13.6
3.9
3.9
mmol/l
1.21
1329
12515
179
1324
1.40
4.07
9.6
7.2
105.2
104.4
mmol/l
1.68
174
1294
1166
10928
1.26
3.85
5.2
5.0
38.3
38.8
mmol/mol
1.16
1113
10203
395
3307
1.26
3.73
1.8
1.7
—
—
—
0
0
27
122
2.23
3.68
1.1
1.2
59.1
62.3
u/l
0.09
17
91
48
268
1.82
3.68
11.1
6.7
672.4
276.4
iu/ml
—
10
38
1231
11635
1.27
3.64
3.9
3.6
1.3
1.3
mmol/l
0.28
1161
10806
279
2244
1.30
3.64
1.3
1.2
56.3
31.5
iu/ml
0.78
81
688
77
493
1.59
3.59
1.2
1.2
0.4
0.9
u/ml
—
9
39
50
287
1.77
3.51
1.1
1.1
20.9
6.2
u/ml
0.71
30
125
32
159
2.03
3.46
1.1
1.3
0.5
0.6
nmol/l
0.42
32
151
1059
9872
1.22
3.42
3.6
3.4
—
—
—
0
0
233
1845
1.31
3.41
1.7
1.7
1153.6
1203.1
nmol/l
0.32
166
1403
77
502
1.56
3.35
1.8
1.7
—
—
—
0
0
125
902
1.42
3.31
2.2
2.4
40.7
20.9
au/ml
—
8
59
1246
11836
1.25
3.27
4.3
4.0
5.7
5.8
mmol/l
1.00
1156
10890
112
796
1.44
3.23
1.5
1.5
25.1
25.0
iu/l
0.01
94
663
1503
14675
1.54
3.18
22.5
18.0
6.8
6.7
e9/l
0.66
1474
14287
130
953
1.40
3.15
10.5
9.1
120.8
122.1
g/l
0.28
125
921
328
2738
1.25
3.14
2.9
3.0
1463.0
1110.1
ng/l
0.58
284
2286
1502
14671
1.53
3.08
22.5
17.9
4.5
4.5
e12/l
0.40
1471
14287
27
132
2.06
3.07
2.5
1.9
—
—
—
0
0
1502
14679
1.51
2.98
22.6
18.1
134.7
135.2
g/l
0.80
1492
14488
89
616
1.47
2.96
1.7
1.7
—
—
—
0
0
44
257
1.73
2.96
1.1
1.1
7.6
6.5
u/ml
0.17
31
125
153
1166
1.35
2.93
5.7
5.6
1.2
1.7
mmol/l
0.80
132
929
152
1160
1.34
2.89
9.4
8.4
5.0
5.1
kpa
0.71
144
1106
152
1160
1.34
2.89
9.4
8.4
12.5
12.6
kpa
0.09
143
1111
32
172
1.88
2.82
1.8
1.3
—
—
—
0
0
151
1158
1.34
2.79
9.5
8.4
0.4
1.1
mmol/l
1.07
118
899
1499
14659
1.48
2.78
22.6
18.0
259.2
257.5
e9/l
0.45
1475
14309
101
1382
0.71
2.78
3.6
4.0
32.8
32.2
%
0.24
75
963
135
1021
1.35
2.73
2.7
2.9
10.1
10.3
g/l
0.21
130
945
116
859
1.38
2.69
3.5
3.4
4.8
4.6
pmol/l
0.25
108
768
78
538
1.47
2.67
13.3
9.9
23.7
24.3
mmol/l
0.83
73
505
230
1882
1.26
2.61
2.5
2.4
93.4
118.6
ug/g
0.95
192
1485
1284
12320
1.23
2.59
4.7
4.3
2.8
2.8
mmol/l
0.61
1216
11463
93
668
1.42
2.58
1.7
1.5
—
—
—
0
0
693
6316
1.17
2.54
3.8
3.4
0.0
0.0
estimate
0.00
121
1217
1262
12101
1.22
2.49
4.1
3.9
1.5
1.5
mmol/l
0.46
1193
11272
116
871
1.36
2.48
1.1
1.0
—
—
—
0
0
1268
12168
1.22
2.46
4.4
4.0
4.7
4.7
mmol/l
1.15
1211
11394
409
3576
1.19
2.43
3.1
3.4
8.4
7.7
mmol/l
1.83
365
3067
53
345
1.55
2.40
1.4
1.4
—
—
—
0
0
15
64
2.36
2.39
1.0
1.2
30.4
24.6
u/l
—
7
50
15
64
2.36
2.39
1.0
1.2
115.6
86.1
u/l
—
8
53
425
3738
1.19
2.36
2.6
2.4
51.6
56.8
u/l
3.07
396
3455
693
6345
1.16
2.34
5.2
4.6
0.0
0.0
estimate
0.50
129
1250
1218
11661
1.20
2.33
13.5
10.8
88.6
87.5
ml/min/173m2
0.90
1005
9388
90
659
1.39
2.27
1.1
1.1
—
1.0
—
0
7
253
2127
1.23
2.26
1.2
1.2
5.0
11.6
u/ml
1.67
97
846
32
186
1.74
2.25
1.7
1.6
—
—
—
0
0
39
242
1.63
2.17
1.1
1.1
0.2
0.5
u/ml
0.93
19
76
6
14
4.30
2.15
1.0
1.3
1.4
1.7
umol/24h
—
6
14
58
396
1.48
2.14
1.1
1.2
—
—
—
0
0
42
267
1.59
2.13
1.4
1.3
—
—
—
0
0
42
267
1.59
2.13
1.4
1.3
—
—
—
0
0
325
2820
1.19
2.09
4.0
3.7
1.0
1.0
kg/l
0.03
31
405
920
8653
1.15
2.05
3.1
3.1
47.2
42.0
u/l
0.81
871
8175
105
805
1.33
2.00
2.2
2.1
11.6
12.3
nmol/l
0.37
93
716
49
328
1.51
2.00
1.4
1.4
222.9
241.8
u/ml
0.23
31
197
15
70
2.15
1.98
1.1
2.0
—
—
—
0
0
15
70
2.15
1.98
1.1
2.0
—
—
—
0
0
694
6411
1.15
1.98
3.8
3.4
0.0
0.0
estimate
0.36
129
1205
134
1068
1.28
1.93
1.2
1.2
108.0
146.7
iu/ml
0.75
52
420
20
106
1.90
1.91
2.5
2.5
—
—
—
0
0
35
220
1.60
1.89
2.7
1.7
—
—
—
0
0
113
887
1.30
1.84
3.6
4.4
80.1
75.7
ng/l
0.25
101
798
88
668
1.34
1.82
1.8
1.6
336.4
312.5
mu/l
0.31
76
597
56
394
1.44
1.81
1.1
1.2
—
—
—
0
0
14
67
2.10
1.76
2.4
1.9
—
—
—
0
0
229
1957
1.20
1.75
3.8
4.0
24.6
21.1
%
1.92
82
856
9
36
2.51
1.74
3.7
7.2
—
—
—
0
0
58
415
1.41
1.73
1.1
1.2
1.7
2.0
u/ml
0.10
32
206
40
266
1.52
1.72
1.2
1.7
—
—
—
0
0
52
365
1.44
1.72
1.1
1.1
0.9
3.2
u/ml
2.23
24
106
46
316
1.47
1.70
1.7
2.3
9.2
11.3
mg/l
1.30
46
293
52
366
1.44
1.70
1.6
1.7
41.7
39.9
nmol/l
0.16
52
354
44
301
1.48
1.66
1.3
1.3
—
—
—
0
0
107
847
1.28
1.66
2.9
2.3
1902.4
4996.4
u/l
1.68
46
333
7
25
2.81
1.65
1.1
4.2
—
—
—
0
0
7
25
2.81
1.65
1.6
1.4
—
—
—
0
0
137
1121
1.24
1.62
2.3
2.6
0.2
0.2
g/l
0.51
128
1056
5
14
3.58
1.61
2.4
1.6
—
—
—
0
0
12
56
2.15
1.61
1.1
1.1
—
—
—
0
0
12
56
2.15
1.61
1.1
1.1
85.8
90.1
%
0.22
12
56
12
56
2.15
1.61
1.2
1.0
68.8
89.8
%
—
5
30
41
279
1.48
1.60
1.6
1.6
126.5
98.1
u/ml
—
10
48
22
129
1.72
1.57
2.8
1.6
—
—
—
0
0
143
1183
1.23
1.54
23.9
20.9
1.3
1.2
inr
0.43
27
166
45
315
1.44
1.54
2.6
1.6
—
—
—
0
0
22
130
1.70
1.53
1.8
2.2
32.1
32.2
pg
0.01
22
130
0
42
0.00
1.52
0.0
1.4
—
—
—
0
0
6
21
2.86
1.50
1.3
2.0
—
—
—
0
0
68
514
1.34
1.49
1.6
2.1
36.2
38.6
u/l
0.48
61
464
40
278
1.45
1.43
1.4
1.3
—
—
—
0
0
24
149
1.62
1.41
2.1
1.8
—
—
—
0
0
34
230
1.49
1.39
1.3
1.2
1.3
4.1
u/ml
—
10
77
13
67
1.95
1.38
1.2
1.4
—
248.3
—
0
6
78
613
1.29
1.32
2.1
1.8
—
—
—
0
0
57
429
1.34
1.31
1.4
1.3
—
—
—
0
0
33
226
1.47
1.29
1.3
1.2
3.4
5.0
u/ml
0.51
17
93
13
69
1.89
1.28
1.2
1.4
5.1
7.0
u/l
0.81
13
56
17
99
1.73
1.27
2.8
2.5
—
—
—
0
0
15
84
1.79
1.27
1.3
1.3
—
—
—
0
0
287
2568
1.14
1.26
1.5
1.4
—
—
—
0
0
55
415
1.34
1.26
1.2
1.1
—
—
—
0
0
37
261
1.43
1.25
1.6
1.7
11217.8
14942.6
e6/l
0.30
26
195
43
312
1.39
1.25
2.7
1.7
—
—
—
0
0
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
20
124
1.62
1.21
1.1
1.5
0.0
0.9
u/ml
—
6
46
109
904
1.22
1.19
3.2
3.5
1.2
1.2
mmol/l
1.40
96
786
121
1015
1.21
1.18
5.6
5.3
5.1
4.8
kpa
0.59
121
982
11
57
1.94
1.17
1.9
1.3
—
—
—
0
0
10
50
2.01
1.16
1.3
1.2
—
—
—
0
0
197
1727
1.16
1.16
1.7
1.8
1.4
1.4
%
0.42
179
1556
18
110
1.64
1.15
2.7
2.5
15.1
11.0
%
0.49
12
71
18
110
1.64
1.15
1.1
1.4
81538.9
101085.2
e6/l
0.08
13
75
24
159
1.52
1.12
2.7
1.5
—
—
—
0
0
11
58
1.90
1.12
1.9
1.3
—
—
—
0
0
96
792
1.23
1.12
2.0
1.7
—
—
—
0
0
31
217
1.44
1.11
1.2
1.1
—
—
—
0
0
274
2468
1.13
1.10
3.9
4.5
1.8
2.2
ug/l
0.92
254
2226
42
559
0.74
1.10
1.5
1.4
—
—
—
0
0
344
3144
1.12
1.09
4.0
4.0
6.1
14.1
mg/mmol
0.78
241
1999
171
1497
1.16
1.04
1.9
2.1
—
—
—
0
0
72
581
1.25
1.04
1.2
1.3
190.9
234.9
miu/ml
0.44
33
297
5
22
2.28
1.03
1.6
1.6
—
—
—
0
0
9
48
1.88
1.00
1.2
1.2
—
—
—
0
0
43
561
0.76
1.00
1.5
1.4
—
—
—
0
0
43
561
0.76
1.00
1.5
1.4
—
—
—
0
0
43
561
0.76
1.00
1.5
1.4
—
—
—
0
0
140
1212
1.17
0.99
1.8
1.9
—
—
—
0
0
61
487
1.26
0.97
1.4
1.3
—
—
—
0
0
31
224
1.39
0.97
1.2
1.1
—
—
—
0
0
71
578
1.24
0.96
2.6
2.7
0.2
0.2
e6/l
0.12
71
554
23
157
1.47
0.96
1.8
1.5
—
—
—
0
0
33
242
1.37
0.95
1.1
1.1
—
—
—
0
0
21
141
1.50
0.95
1.0
1.0
—
—
—
0
0
39
294
1.33
0.95
1.8
1.8
—
—
—
0
0
31
225
1.39
0.95
3.1
2.4
17.0
16.5
%
0.29
14
119
41
312
1.32
0.94
2.3
2.7
—
—
—
0
0
321
2949
1.11
0.93
2.6
2.2
—
—
—
0
0
51
404
1.27
0.88
1.5
2.0
0.7
2.0
ug/l
0.97
45
362
13
79
1.65
0.88
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
87
1.61
0.87
1.0
1.2
—
—
—
0
0
16
103
1.56
0.87
1.2
1.1
—
—
—
0
0
16
103
1.56
0.87
1.2
1.1
—
—
—
0
0
16
103
1.56
0.87
1.2
1.1
—
—
—
0
0
16
103
1.56
0.87
1.2
1.1
—
—
—
0
0
15
95
1.58
0.87
1.3
1.4
4.9
5.2
umol/l
0.11
15
88
11
64
1.72
0.86
1.1
1.2
—
—
—
0
0
516
4870
1.09
0.86
4.0
3.5
—
—
—
0
0
17
112
1.52
0.85
5.5
2.4
510.1
615.3
e6/l
0.47
11
92
17
112
1.52
0.85
1.0
1.1
—
—
—
0
0
16
104
1.54
0.84
1.2
1.1
—
—
—
0
0
36
274
1.32
0.84
1.5
1.6
—
—
—
0
0
21
146
1.44
0.82
1.0
1.1
—
—
—
0
0
20
138
1.46
0.81
1.5
1.4
9.2
12.2
mmol/l
—
8
22
111
963
1.16
0.80
3.6
4.3
13.5
13.4
ug/l
0.00
83
780
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
6
33
1.82
0.79
1.2
1.5
—
—
—
0
0
16
106
1.51
0.79
3.4
1.5
—
—
—
0
0
16
106
1.51
0.79
3.4
1.5
—
—
—
0
0
16
106
1.51
0.79
3.4
1.5
—
—
—
0
0
11
66
1.67
0.78
1.0
1.2
—
—
—
0
0
15
99
1.52
0.75
1.7
1.4
1.5
1.4
nmol/l
0.13
15
88
29
218
1.34
0.75
1.8
1.5
—
—
—
0
0
50
613
0.81
0.75
1.5
1.5
—
—
—
0
0
65
542
1.21
0.74
1.5
1.4
—
—
—
0
0
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
61
506
1.21
0.74
6.2
4.3
0.7
0.7
%
0.04
61
486
16
108
1.49
0.73
5.6
2.4
0.3
0.2
e9/l
0.61
11
91
433
4084
1.08
0.73
3.3
3.2
29.9
37.0
ng/l
0.43
246
2493
9
56
1.61
0.72
4.9
1.5
—
—
—
0
0
9
56
1.61
0.72
4.9
1.5
—
—
—
0
0
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
9
56
1.61
0.72
4.9
1.5
—
—
—
0
0
9
56
1.61
0.72
4.9
1.5
—
—
—
0
0
9
58
1.55
0.69
1.0
1.3
—
—
—
0
0
21
153
1.38
0.67
1.0
1.1
—
—
—
0
0
5
28
1.79
0.66
1.2
1.5
—
—
—
0
0
12
78
1.54
0.65
1.1
1.0
—
—
—
0
0
12
78
1.54
0.65
2.0
1.8
—
—
—
0
0
59
496
1.20
0.64
1.7
1.5
9.1
8.8
u/l
0.06
45
395
74
635
1.17
0.64
6.1
8.6
24.6
24.5
mmol/l
0.04
69
592
22
163
1.35
0.64
1.3
1.1
84.7
95.6
%
1.06
22
153
18
129
1.40
0.63
1.8
1.8
70.2
60.0
%
—
10
87
33
261
1.27
0.62
2.8
3.5
17.8
23.7
mg/l
0.59
19
165
12
79
1.52
0.62
1.0
1.1
—
—
—
0
0
35
279
1.26
0.62
1.8
1.3
—
—
—
0
0
5
30
1.67
0.61
3.2
2.6
—
—
—
0
0
45
371
1.22
0.60
3.0
2.0
6.3
5.2
iu/l
0.18
18
139
43
353
1.22
0.60
1.5
1.4
293.3
309.9
ug/g
0.16
24
194
8
52
1.54
0.59
2.1
1.3
—
—
—
0
0
8
52
1.54
0.59
2.1
1.3
—
—
—
0
0
8
52
1.54
0.59
1.0
1.2
—
—
—
0
0
50
418
1.20
0.59
1.1
1.1
5.9
5.6
u/ml
—
8
60
14
97
1.45
0.59
1.1
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.9
—
7.5
—
0
12
26
202
1.29
0.57
1.2
1.1
—
—
—
0
0
264
2467
1.08
0.57
2.5
2.3
—
—
—
0
0
22
167
1.32
0.57
1.5
1.3
—
—
—
0
0
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
21
159
1.33
0.55
1.6
1.5
—
—
—
0
0
15
107
1.41
0.55
1.5
1.4
—
—
—
0
0
18
134
1.35
0.53
1.6
1.5
—
—
—
0
0
9
62
1.45
0.53
1.8
1.7
—
—
—
0
0
9
62
1.45
0.53
1.8
1.7
—
—
—
0
0
147
1344
1.10
0.52
8.2
6.1
—
—
—
0
0
155
1422
1.10
0.51
2.5
2.8
0.6
0.7
ug/l
0.99
90
880
6
40
1.50
0.51
2.2
1.3
—
—
—
0
0
9
65
1.39
0.50
1.1
1.1
1663.2
1543.0
miu/ml
—
9
65
35
288
1.22
0.50
1.4
1.4
—
—
—
0
0
6
41
1.47
0.50
1.3
2.3
23.6
16.2
umol/l
—
6
41
59
511
1.16
0.49
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
308
1.21
0.48
3.5
5.1
0.4
0.4
u/ml
0.05
17
174
336
3192
1.07
0.48
1.8
1.7
1.4
1.4
mmol/l
0.19
292
2730
240
2253
1.08
0.48
2.3
2.1
—
—
—
0
0
13
94
1.39
0.46
4.9
3.7
—
—
—
0
0
250
2356
1.07
0.45
1.6
1.6
85454980.8
29320329.7
pmol/l
0.49
220
1985
7
50
1.40
0.45
1.9
2.4
—
—
—
0
0
101
915
1.11
0.44
2.3
2.5
64.0
71.7
ml/min/173m2
0.82
40
355
99
1091
0.90
0.44
1.5
1.5
—
—
—
0
0
33
275
1.20
0.43
3.6
3.7
4.3
4.1
e9/l
0.24
33
275
142
1312
1.09
0.43
1.5
1.6
—
—
—
0
0
355
3393
1.06
0.42
4.3
3.7
0.0
0.0
estimate
0.10
125
1217
5
32
1.56
0.42
1.2
1.3
—
—
—
0
0
126
1160
1.09
0.41
3.2
2.9
—
—
—
0
0
13
96
1.36
0.41
2.1
2.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
3.1
—
0.7
—
0
15
0
15
0.00
0.41
0.0
1.7
—
1.0
—
0
9
0
15
0.00
0.41
0.0
3.7
—
7.5
—
0
15
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
5
34
1.47
0.40
1.4
1.4
7.5
8.7
ug/l
—
5
34
20
159
1.26
0.40
2.1
1.6
7.8
7.4
mmol/l
0.32
11
93
14
106
1.32
0.39
1.0
1.2
—
—
—
0
0
15
115
1.31
0.39
1.0
1.5
7.4
11.1
umol/l
4.26
15
109
45
391
1.16
0.39
1.8
1.9
—
—
—
0
0
12
89
1.35
0.38
1.7
1.7
—
—
—
0
0
14
107
1.31
0.37
1.0
1.2
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
31
262
1.19
0.37
2.3
2.7
4.5
7.4
umol/l
1.43
26
192
17
134
1.27
0.37
4.5
4.3
12.8
70.6
u/ml
—
5
35
10
72
1.39
0.37
1.7
1.6
—
—
—
0
0
33
281
1.18
0.36
4.2
3.9
57.5
56.6
%
0.18
33
281
31
264
1.18
0.34
1.3
1.2
—
—
—
0
0
20
163
1.23
0.34
2.3
1.4
—
—
—
0
0
34
294
1.16
0.32
1.2
1.2
—
—
—
0
0
54
483
1.12
0.32
1.8
1.7
—
—
—
0
0
22
183
1.21
0.32
1.6
1.5
—
—
—
0
0
15
120
1.25
0.30
1.0
1.4
—
—
—
0
0
37
325
1.14
0.29
1.3
1.5
82.6
170.9
pmol/l
0.97
37
318
7
56
1.25
0.29
2.4
4.3
—
—
—
0
0
36
316
1.14
0.29
1.3
1.2
1.9
12.2
u/ml
—
5
57
29
251
1.16
0.28
2.6
2.3
130.8
131.4
g/l
0.05
22
191
93
864
1.08
0.28
1.3
1.4
—
—
—
0
0
23
195
1.18
0.28
1.9
1.4
7.2
7.2
mmol/l
0.00
17
132
8
65
1.23
0.27
1.3
1.2
—
8.3
u/ml
—
0
9
8
67
1.20
0.26
2.1
2.4
22.2
139.9
ug/l
—
8
59
18
214
0.84
0.26
2.0
4.2
23.3
28.8
u/ml
0.20
18
208
48
530
0.90
0.26
1.4
1.6
—
—
—
0
0
48
434
1.11
0.26
1.4
1.6
0.2
0.2
iu/ml
—
10
77
19
160
1.19
0.25
2.4
1.4
—
—
—
0
0
15
123
1.22
0.25
2.0
2.2
19.0
30.4
mg/l
—
6
32
15
123
1.22
0.25
1.1
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
19
162
1.17
0.23
2.4
1.4
—
—
—
0
0
7
95
0.74
0.22
1.6
1.4
—
—
—
0
0
8
105
0.76
0.21
1.0
1.2
—
250.0
—
0
18
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
51
470
1.09
0.20
5.0
4.0
53.8
50.2
%
0.48
51
462
0
14
0.00
0.20
0.0
1.7
—
7.3
—
0
9
0
14
0.00
0.20
0.0
1.7
—
2.4
—
0
8
0
14
0.00
0.20
0.0
1.7
—
3.5
—
0
7
42
384
1.10
0.20
2.5
1.8
—
—
—
0
0
38
346
1.10
0.19
1.6
1.5
—
—
—
0
0
16
137
1.17
0.18
1.2
2.1
—
—
—
0
0
64
600
1.07
0.18
2.0
1.9
—
—
—
0
0
25
224
1.12
0.17
2.1
1.5
—
—
—
0
0
24
215
1.12
0.16
4.0
5.8
375.6
385.4
umol/l
0.11
18
193
22
196
1.12
0.16
1.5
1.7
—
1506.7
—
0
6
8
71
1.13
0.16
3.5
6.4
—
70.4
—
0
17
26
235
1.11
0.15
1.0
1.1
6.1
3.3
u/ml
—
10
106
11
93
1.18
0.14
1.4
1.3
24.1
32.9
nmol/l
0.56
11
82
23
208
1.11
0.14
1.7
1.4
—
—
—
0
0
22
199
1.11
0.13
3.9
3.0
8.3
7.3
mmol/l
1.13
22
194
13
113
1.15
0.13
1.5
1.5
—
—
—
0
0
11
94
1.17
0.13
1.0
1.6
29.6
25.3
umol/l
0.16
11
88
94
903
1.04
0.13
5.7
6.2
1.4
1.4
mmol/l
0.01
67
660
40
374
1.07
0.13
4.1
4.2
1.4
1.3
mmol/l
0.17
40
366
46
433
1.06
0.12
3.3
1.8
—
—
—
0
0
61
581
1.05
0.12
1.3
1.7
5.8
4.4
mg/l
0.22
40
391
10
86
1.16
0.11
1.3
1.1
—
1.8
—
0
5
5
44
1.14
0.10
7.4
1.6
—
—
—
0
0
5
44
1.14
0.10
7.4
1.6
—
—
—
0
0
5
45
1.11
0.09
7.4
1.6
—
—
—
0
0
6
56
1.07
0.08
1.5
2.1
—
252.4
—
0
9
9
88
1.02
0.07
1.3
2.5
—
—
—
0
0
9
101
0.89
0.06
7.2
14.4
795.4
797.6
nmol/l
—
9
96
9
105
0.86
0.06
4.2
1.8
—
—
—
0
0
10
90
1.11
0.05
1.1
1.5
—
—
—
0
0
10
91
1.10
0.04
1.4
1.1
—
69.1
—
0
10
10
91
1.10
0.04
1.4
1.1
—
38.2
—
0
6
95
936
1.02
0.03
5.7
6.2
5.2
5.1
kpa
0.31
88
887
17
161
1.06
0.03
2.5
1.4
—
—
—
0
0
17
161
1.06
0.03
2.5
1.4
—
—
—
0
0
17
162
1.05
0.02
2.5
1.4
—
—
—
0
0
44
431
1.02
0.02
1.5
1.5
—
—
—
0
0
13
137
0.95
0.01
1.0
1.1
—
—
—
0
0
70
692
1.01
0.01
1.5
1.4
—
—
—
0
0
11
116
0.95
0.00
1.1
1.1
—
—
—
0
0
10
96
1.04
0.00
2.2
1.6
—
—
—
0
0
14
144
0.97
0.00
1.7
1.1
—
—
—
0
0
15
148
1.01
0.00
1.4
1.1
—
—
—
0
0
22
218
1.01
0.00
3.9
2.8
1.8
1.5
mmol/l
1.43
22
212
24
241
1.00
0.00
4.6
2.4
96.9
113.0
ug/min
0.07
16
151
10
97
1.03
0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.2
1.2
1.3
4.1
u/ml
—
5
45
6
64
0.94
0.00
1.2
1.3
102.3
398.5
u/l
—
6
59
5
55
0.91
0.00
1.6
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
9
98
0.92
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_SKIN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_SKIN | 1.014 [0.88, 1.17] | 0.843 |
| Birth year | 1.0 [0.99, 1.01] | 0.907 |
During the follow-up period (1.1.1998 — 31.12.2019), 482 out of 9147 females with Q17_OTHER_CONGEN_MALFO_SKIN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_SKIN | 1.033 [0.9, 1.18] | 0.638 |
| Birth year | 0.989 [0.98, 1.0] | 0.024 |
During the follow-up period (1.1.1998 — 31.12.2019), 444 out of 6458 males with Q17_OTHER_CONGEN_MALFO_SKIN died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_SKIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.131% | 0.204% |
| 5 | 0.653% | 1.158% |
| 10 | 1.623% | 3.183% |
| 15 | 3.116% | 6.268% |
| 20 | 5.536% | 10.467% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_SKIN – Other congenital malformations of skin
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data